Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiba El Sayadi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|November 14, 2008
[Targeted therapy of sarcomas]Philippe A Cassier, Armelle Dufresne, Hiba El Sayadi, et al.
Current Gastroenterology Reports|November 14, 2008
Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinibPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumorsSéverine Tabone-Eglinger, Frédéric Subra, Hiba El Sayadi, et al.
Targeted Oncology|January 29, 2013
Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomasHiba el Sayadi, Daniel Pissaloux, Laurent Alberti, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
British Journal of Cancer|October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcomaCarmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|November 14, 2008
[Targeted therapy of sarcomas]Philippe A Cassier, Armelle Dufresne, Hiba El Sayadi, et al.
Current Gastroenterology Reports|November 14, 2008
Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinibPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2008
KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumorsSéverine Tabone-Eglinger, Frédéric Subra, Hiba El Sayadi, et al.
Targeted Oncology|January 29, 2013
Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomasHiba el Sayadi, Daniel Pissaloux, Laurent Alberti, et al.
Bulletin Du Cancer|January 31, 2008
[Imatinib and solid tumours]Samia Arifi, Hiba El Sayadi, Armelle Dufresne, et al.
Expert Opinion on Pharmacotherapy|April 22, 2008
Imatinib mesilate for the treatment of gastrointestinal stromal tumourPhilippe A Cassier, Armelle Dufresne, Samia Arifi, et al.
British Journal of Cancer|October 13, 2017
Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcomaCarmela Dantas-Barbosa, Tom Lesluyes, François Le Loarer, et al.
Pageof 1